Efficacy of rho kinase inhibitor on cognitive impairment induced by chronic cerebral hypoperfusion in rats

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 2, 2015, Pages 2435-2440

  Zhang, Qiang ^a   Zhang, Jun Jian ^a   Han, Zhong Mou ^b  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Department of Neurology Three Gorges University First Clinical Medical College   (China)

Author keywords

Chronic cerebral hypoperfusion; Mild cognitive impairment; Rho kinase inhibitor

Indexed keywords

FASUDIL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY OBSTRUCTION; CHRONIC CEREBRAL HYPOPERFUSION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFICACY; MALE; MORPHOLOGY; MORRIS WATER MAZE TEST; NONHUMAN; PERFUSION; RAT;

RATTUS;

EID: 84926352884     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Barnett HJ. Carotid disease and cognitive dysfunction. Ann Intern Med 2004; 140: 303-304.
2. Matsumoto K, Murakami Y. Neuronal damage and decrease of central aeetylcholine level following permanent occlusion of bilateral common carotid arteries in rat. Brain Rest 1995; 673: 290-296.
3. Demarin V, Zavoreo I, Kes VB. Carotid artery disease and cognitive impairment. J Neurol Sci 2012; 322: 107-111.
4. Kwon BJ, Han MH, Kang HS, Jung C. Protection filter-related events in extracranial carotid artery stenting: a single-center experience. J Endovasc Ther 2006; 13: 711-722.
5. Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP, Larrue V, Lièvre M, Leys D, Bonneville JF, Watelet J, Pruvo JP, Albucher JF, Viguier A, Piquet P, Garnier P, Viader F, Touzé E, Giroud M, Hosseini H, Pillet JC, Favrole P, Neau JP, Ducrocq X. EVA-3S Investigators. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006; 355: 1660-1671.
6. Shibuya M, Hirai S, Seto M, Satoh S, Ohtomo E. Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial. J Neurol Sci 2005; 238: 31-39.
7. Sun X, Minohara M, Kikuchi H, Ishizu T, Tanaka M, Piao H, Osoegawa M, Ohyagi Y, Shimokawa H, Kira J. The selective Rho-kinase inhibitor Fasudil is protective and therapeutic in experimental autoimmune encephalomyelitis. J Neuroimmunol 2006; 180: 126-134.
8. Huang L, He Z, Guo L, Wang H. Improvement of cognitive deficit and neuronal damage in rats with chronic cerebral ischemia via relative long-term inhibition of rho-kinase. Cell Mol Neurobiol 2008; 28: 757-768.
9. Zhou Z, Zhang Y, Zhu C, Sui J, Wu G, Meng Z, Huang H, Chen K. Cognitive functions of carotid artery stenosis in the aged rat. Neuroscience 2012; 219: 137-144.
10. Wu QY, Li J, Feng ZT, Wang TH. Bone marrow stromal cells of transgenic mice can improve the cognitive ability of an Alzheimer’s disease rat model. Neurosci Lett 2007; 417: 281-285.
11. Hachinski VC, Bowler JV. Vascular demetia. Neurology 1993; 43: 2159-2160.
12. Sztriha LK, Nemeth D, Sefcsik T, Vecsei L. Carotid stenosis and the cognitive function. J Neurol Sci 2009; 283: 36-40.
13. Hojo Y, Hattori TA, Enami T, Furukawa A, Suzuki K, Ishii HT, Mukai H, Morrison JH, Janssen WG, Kominami S, Harada N, Kimoto T, Kawato S. Adult male rat hippocampus synthesizes estradiol from pregnenolone by cytochromes P45017 alpha and P450 aromatase localized in neurons. Proc Natl Acad Sci U S A 2004; 101: 865-870.
14. Mueller BK, Mack H, Teusch N. Rho kinase, a promising drug target for neurological disorders. Nat Rev Drug Discov 2005; 4: 387-398.
15. Yagita Y, Kitagawa K, Sasaki T. Rho-kinase activation in endothelial cells contributes to expansion of infarction after focal cerebral ischemia. J Neurosci Res 2007; 85: 2460-2469.
16. Pluta RM. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol Ther 2005; 105: 23-56.
17. Chrissobolis S, Sobey CG. Recent evidence for an involvement of rho-kinase in cerebral vascular disease. Stroke 2006; 37: 2174-2180.
18. Rikitake Y, Kim HH, Huang Z, Seto M, Yano K, Asano T, Moskowitz MA, Liao JK. Inhibition of rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke 2005; 36: 2251-2257.
19. Koelemay MJ, Nederkoorn PJ, Reitsma JB, Majoie CB. Systematic review of computed tomographic angiography for assessment of carotid artery disease. Stroke 2004; 35: 2306-2312.
20. Hirooka Y, Shimokawa H. Therapeutic potential of Rho-kinase inhibitors in cardiovascular diseases. Am J Cardiovasc Drugs 2005; 5: 31-39.
21. Matsumoto Y, Uwatoku T, Oi K, Abe K, Hattori T, Morishige K, Eto Y, Fukumoto Y, Nakamura K, Shibata Y, Matsuda T, Takeshita A, Shimokawa H. Long-term inhibition of Rho-kinase suppresses neointimal formation after stent implantation in porcine coronary arteries: involvement of multiple mechanisms. Arterio-scler Thromb Vasc Biol 2004; 24: 181-186.
22. Satoh S, Toshima Y, Ikegaki I, Iwasaki M, Asano T. Wide therapeutic time window for fasudil neuroprotection against ischemia-induced delayed neuronal death in gerbils. Brain Res 2007; 1128: 175-180.